Prostate cancer Board decisions

The Veteran's claims for higher ratings for diabetes, right and left lower extremity neuropathy, and prostate cancer have been dismissed.,Higher ratings were granted for upper extremity neuropathies but the Veteran withdrew his claims for higher ratings of diabetes and lower extremity radiculopathy.

The Board has determined that further development is necessary to verify the Veteran's in-service stressors and obtain medical opinions regarding his psychiatric, prostate cancer residuals, COPD, dementia, and sleep disorder claims. The issues have been remanded for these purposes.

The Board denied service connection for prostate cancer as there was no evidence of in-service exposure to herbicide agents and the Veteran's private and VA treatment records did not provide an opinion linking his current condition to service.

The Board has remanded the claim for service connection for a prostate disorder, including prostate cancer, due to lack of notification for a VA examination. The Veteran is required to be notified again and must report for the scheduled examination.

The Board denied the Veteran's petitions to reopen his service connection claims for diabetes, asthma, and prostate cancer. The appeals were based on a lack of new and material evidence or due to the absence of a causal relationship between the conditions and military service.

The Veteran's claim for an initial compensable disability rating for bilateral hearing loss disability is denied.,The Veteran's claim for an effective date earlier than September 13, 2021, for the grant of service connection for PTSD is denied. The appeal as to this issue is remanded.

The Veteran's prostate cancer, hypertension, and ischemic heart disease are being remanded for further examination and medical opinions to determine their relationship to service exposure. The claims will be considered on the merits.

The Board denied an earlier effective date for the grant of TDIU, finding that the Veteran did not meet the schedular requirements for a TDIU prior to December 11, 2015.

The Veteran's claims of service connection for prostate cancer and Parkinson's disease are granted due to presumed exposure to herbicide agents during service.,Service connection for tinnitus is restored as it was improperly severed.

The Veteran's service connection claims for prostate cancer, erectile dysfunction as secondary to prostate cancer, hypertension, arthritis, heart condition, fatigue (including CFS), and a condition of the bilateral upper extremities (peripheral neuropathy) are granted. The conditions are presumed due to exposure to burn pits during service in Egypt.

The Veteran's prostate cancer reduced from a 100% rating to a 40% rating effective October 1, 2018. The appeal for an increased disability rating is denied.

The Veteran's prostate cancer is granted as service connected due to presumed exposure to herbicide agents while stationed at the Thai Air Force base from June 1971 to March 1972.

The Veteran's death was due to esophageal cancer with metastasis, and the Board is remanding for further evidence on whether herbicide exposure made him more susceptible to lung cancer.

The Veteran's service-connected prostate cancer and bone metastasis are rated at 100% based on their current status, but the Board finds that these ratings cannot be considered permanent due to regulatory provisions. Therefore, a permanent and total disability rating is denied.

The Board denied a higher disability rating for prostate cancer, status post prostatectomy with ED, and also denied an earlier effective date than February 2, 2022, for the assignment of a 60 percent disability rating.

The Veteran's prostate cancer is presumed to be due to in-service herbicide exposure at Udorn RTAFB, Thailand. Service connection for prostate cancer residuals is granted.

The Veteran is granted a total disability rating based on individual unemployability due to service-connected disabilities, effective August 10, 2022. The claim for TDIU is dismissed as the service-connected prostate cancer alone grants a 100% schedular rating and special monthly compensation (SMC) under 38 U.S.C. § 1114(s).

The Veteran's appeal for prostate cancer has been withdrawn. His TDIU claim is granted, and the Board finds that his service-connected disabilities prevent him from securing or following a substantially gainful occupation. The claims for headaches, hemorrhoids, peripheral neuropathy, skin disorder (other than alopecia areata), and back disability are all remanded.

The Board denied service connection for prostate cancer, ED, and a mental condition as secondary to prostate cancer due to exposure at Camp LeJeune. The claims were reopened based on new evidence received within one year of the April 2017 rating decision.

The Board denied service connection for throat tumor due to the lack of evidence showing a current disability or functional impairment after October 2011. The prostate cancer and erectile dysfunction claims are remanded for further development.,Additional research is needed regarding the Veteran's exposure to ionizing radiation, particularly considering his assertions of more frequent exposure than others at the Nevada Test Site.